157 related articles for article (PubMed ID: 23934415)
1. Identification of genes and candidate agents associated with pancreatic cancer.
Wang BS; Liu Z; Sun SL; Zhao Y
Tumour Biol; 2014 Jan; 35(1):81-8. PubMed ID: 23934415
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
Liu J; Li J; Li H; Li A; Liu B; Han L
Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of transcription profiling of solid pseudopapillary neoplasm of the pancreas.
Zhang Y; Han X; Wu H; Zhou Y
Mol Med Rep; 2017 Aug; 16(2):1635-1642. PubMed ID: 28627654
[TBL] [Abstract][Full Text] [Related]
4. Analysis of molecular pathways in pancreatic ductal adenocarcinomas with a bioinformatics approach.
Wang Y; Li Y
Asian Pac J Cancer Prev; 2015; 16(6):2561-7. PubMed ID: 25824797
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
6. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data.
Li N; Zhao X; You S
Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213
[TBL] [Abstract][Full Text] [Related]
7. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
9. Construction of pancreatic cancer double-factor regulatory network based on chip data on the transcriptional level.
Zhao LL; Zhang T; Liu BR; Liu TF; Tao N; Zhuang LW
Mol Biol Rep; 2014 May; 41(5):2875-83. PubMed ID: 24469724
[TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel therapeutic target genes and pathway in pancreatic cancer by integrative analysis.
Hu B; Shi C; Jiang HX; Qin SY
Medicine (Baltimore); 2017 Oct; 96(42):e8261. PubMed ID: 29049217
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the autophagy gene expression profile of pancreatic cancer based on autophagy-related protein microtubule-associated protein 1A/1B-light chain 3.
Yang YH; Zhang YX; Gui Y; Liu JB; Sun JJ; Fan H
World J Gastroenterol; 2019 May; 25(17):2086-2098. PubMed ID: 31114135
[TBL] [Abstract][Full Text] [Related]
13. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
Yang ZQ; Liu YJ; Zhou XL
Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
[TBL] [Abstract][Full Text] [Related]
14. Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis.
Wu J; Li Z; Zeng K; Wu K; Xu D; Zhou J; Xu L
Mol Med Rep; 2019 Aug; 20(2):1343-1352. PubMed ID: 31173193
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
Li C; Zeng X; Yu H; Gu Y; Zhang W
World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
[TBL] [Abstract][Full Text] [Related]
17. Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells.
Xu Q; Fu R; Yin G; Liu X; Liu Y; Xiang M
Gene; 2016 Mar; 578(2):263-73. PubMed ID: 26719042
[TBL] [Abstract][Full Text] [Related]
18. Screening key candidate genes and pathways involved in insulinoma by microarray analysis.
Zhou W; Gong L; Li X; Wan Y; Wang X; Li H; Jiang B
Medicine (Baltimore); 2018 Jun; 97(22):e10826. PubMed ID: 29851790
[TBL] [Abstract][Full Text] [Related]
19. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
[TBL] [Abstract][Full Text] [Related]
20. Identification of key pathways and genes changes in pancreatic cancer cells (BXPC-3) after cross-talk with primary pancreatic stellate cells using bioinformatics analysis.
Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
Neoplasma; 2019 Sep; 66(5):681-693. PubMed ID: 31169017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
